Mozart Therapeutics raises $55M to advance disease therapies
October 26, 2021 at 16:04 PM EDT
The Seattle company is developing treatments for celiac disease and inflammatory bowel disease.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.